Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Agilent Technologies; Dionex; UCSF

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies this week said that it had completed the acquisition of certain assets of A2 Technologies for an undisclosed sum. Agilent inked the agreement last month to acquire specific assets of A2 Technologies, a Danbury, Conn.-based developer of Fourier transform infrared technology for lab and field use.

Dionex this week reported that its second-quarter revenues increased around 14 percent to $124.1 million from $109.2 million year over year. The firm's net income was $18.9 million, or $1.04 per share, compared to $16.9 million, or $.92 per share, for the second quarter of the previous year.

The chromatography systems maker signed a deal in December to be acquired by Thermo Fisher Scientific for approximately $2.1 billion.

The University of California, San Francisco, this week opened its $123 million Ray and Dagmar Dolby Regeneration Medicine Building. The new facility houses the Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research at UCSF. No federal funds were used in constructing the facility or purchasing equipment for it, meaning the research conducted there is immune to variations in federal funding policy regarding human embryonic stem cell research, UCSF said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.